Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective
S Bindu, S Mazumder, U Bandyopadhyay - Biochemical pharmacology, 2020 - Elsevier
Owing to the efficacy in reducing pain and inflammation, non-steroidal anti-inflammatory
drugs (NSAIDs) are amongst the most popularly used medicines confirming their position in …
drugs (NSAIDs) are amongst the most popularly used medicines confirming their position in …
[HTML][HTML] An update on current therapeutic drugs treating COVID-19
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms
INTRODUCTION The emergence of three lethal coronaviruses in< 20 years and the urgency
of the COVID-19 pandemic have prompted efforts to develop new therapeutic strategies …
of the COVID-19 pandemic have prompted efforts to develop new therapeutic strategies …
COVID-19, immune system response, hyperinflammation and repurposingantirheumatic drugs
Abstract In the Wuhan Province of China, in December 2019, the novel coronavirus 2019
(COVID-19) has caused a severe involvement of the lower respiratory tract leading to an …
(COVID-19) has caused a severe involvement of the lower respiratory tract leading to an …
Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID‐19 patients in Michigan, United States
Introduction Higher comorbidity and older age have been reported as correlates of poor
outcomes in COVID‐19 patients worldwide; however, US data are scarce. We evaluated …
outcomes in COVID‐19 patients worldwide; however, US data are scarce. We evaluated …
[HTML][HTML] Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
B Russell, C Moss, G George, A Santaolalla… - …, 2020 - ncbi.nlm.nih.gov
Background Cancer and transplant patients with COVID-19 have a higher risk of developing
severe and even fatal respiratory diseases, especially as they may be treated with immune …
severe and even fatal respiratory diseases, especially as they may be treated with immune …
Novel canine coronavirus isolated from a hospitalized patient with pneumonia in East Malaysia
Background During the validation of a highly sensitive panspecies coronavirus (CoV)
seminested reverse-transcription polymerase chain reaction (RT-PCR) assay, we found …
seminested reverse-transcription polymerase chain reaction (RT-PCR) assay, we found …
[HTML][HTML] COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
B Russell, C Moss, A Rigg… - …, 2020 - ncbi.nlm.nih.gov
Given the current SARS-CoV-2 (COVID-19) pandemic, the availability of reliable information
for clinicians and patients is paramount. There have been a number of reports stating that …
for clinicians and patients is paramount. There have been a number of reports stating that …
COVID-19 and gastrointestinal disease: implications for the gastroenterologist
Background: COVID-19 was initially considered a respiratory disease but the SARS-CoV-2
virus can lead to serious systemic consequences affecting major organs including the …
virus can lead to serious systemic consequences affecting major organs including the …
[HTML][HTML] Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents
N Perico, M Cortinovis, F Suter… - The Lancet Infectious …, 2023 - thelancet.com
Summary COVID-19, caused by SARS-CoV-2, is characterised by a broad spectrum of
symptom severity that requires varying amounts of care according to the different stages of …
symptom severity that requires varying amounts of care according to the different stages of …